Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tappei Takada

Showing results (1-10 of 153) with videos related to

Pageof 16
Sort By:
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2013
[Transporter-mediated regulation of pharmacokinetics of lifestyle-related substances]Tappei Takada
Seikagaku. the Journal of Japanese Biochemical Society|February 23, 2012
[Urate exporter gene ABCG 2/BCRP and gout risk]Tappei Takada, Hirotaka Matsuo
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2004
[Transporters for bile lipids]Tappei Takada, Hiroshi Suzuki
Molecular Nutrition & Food Research|March 6, 2010
Molecular mechanisms of membrane transport of vitamin ETappei Takada, Hiroshi Suzuki
Drug Metabolism and Pharmacokinetics|February 25, 2020
PrefaceTappei Takada, Tomohiro Nishimura
Pharmaceutical Research|December 15, 2007
HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1Yuki Iwayanagi, Tappei Takada, Hiroshi Suzuki
Pharmacogenetics and Genomics|October 14, 2009
In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbersYoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki
The Journal of Dermatology|July 25, 2020
Febuxostat inhibited axillary osmidrosis risk factor ATP-binding cassette transporter C11 in vitroYu Toyoda, Tappei Takada, Hiroshi Suzuki
Biological & Pharmaceutical Bulletin|January 10, 2018
Associations between Lifestyle-Related Diseases and Transporters Involved in Intestinal Absorption and Biliary Excretion of CholesterolYoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki
Pharmaceutical Research|April 20, 2005
Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cellsTappei Takada, Hiroshi Suzuki, Yuichi Sugiyama
Pageof 16

Showing results (1-10 of 153) with videos related to

Sort By:
Pageof 16
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|April 3, 2013
[Transporter-mediated regulation of pharmacokinetics of lifestyle-related substances]Tappei Takada
Seikagaku. the Journal of Japanese Biochemical Society|February 23, 2012
[Urate exporter gene ABCG 2/BCRP and gout risk]Tappei Takada, Hirotaka Matsuo
Seikagaku. the Journal of Japanese Biochemical Society|August 4, 2004
[Transporters for bile lipids]Tappei Takada, Hiroshi Suzuki
Molecular Nutrition & Food Research|March 6, 2010
Molecular mechanisms of membrane transport of vitamin ETappei Takada, Hiroshi Suzuki
Drug Metabolism and Pharmacokinetics|February 25, 2020
PrefaceTappei Takada, Tomohiro Nishimura
Pharmaceutical Research|December 15, 2007
HNF4alpha is a crucial modulator of the cholesterol-dependent regulation of NPC1L1Yuki Iwayanagi, Tappei Takada, Hiroshi Suzuki
Pharmacogenetics and Genomics|October 14, 2009
In-vitro characterization of the six clustered variants of NPC1L1 observed in cholesterol low absorbersYoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki
The Journal of Dermatology|July 25, 2020
Febuxostat inhibited axillary osmidrosis risk factor ATP-binding cassette transporter C11 in vitroYu Toyoda, Tappei Takada, Hiroshi Suzuki
Biological & Pharmaceutical Bulletin|January 10, 2018
Associations between Lifestyle-Related Diseases and Transporters Involved in Intestinal Absorption and Biliary Excretion of CholesterolYoshihide Yamanashi, Tappei Takada, Hiroshi Suzuki
Pharmaceutical Research|April 20, 2005
Characterization of polarized expression of point- or deletion-mutated human BCRP/ABCG2 in LLC-PK1 cellsTappei Takada, Hiroshi Suzuki, Yuichi Sugiyama
Pageof 16